Breaking Barriers: A New Hope for Lung Cancer Treatment
Lung cancer is a tough opponent, especially when it's the non-small-cell kind (NSCLC). Doctors usually don't recommend a common treatment called EGFR-TKIs for a specific mutation called EGFR exon 20 insertion. Why? Because these mutations don't respond well to the treatment. But here's a twist: a specific subtype called A763_Y763insFQEA shows a bit of sensitivity to ...